OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
606357

Emergency Assistance Japan Co Ltd

Healthcare Facilities & ServicesVerified

Emergency Assistance Japan maintains a strong liquidity position with JPY 2.49 billion in cash and equivalents, representing 65.3% of total assets. The company's liquidity_fpt of 2.49 indicates a robust ability to cover short-term obligations, supported by a current ratio of 1.9. However, the low liquidity risk score suggests minimal pressure from short-term debt maturities. Profitability metrics show a return on equity (ROE) of 5.4% and return on assets (ROA) of 2.67%, both below the industry median for Healthcare Facilities & Services. The operating margin of 3.05% (JPY 113.4 million operating income on JPY 3.71 billion revenue) reflects moderate efficiency in converting revenue to profit. The company operates in two segments: Medical Assistance and Life Assistance. The Medical Assistance segment focuses on overseas medical support, while the Life Assistance segment provides concierge services for credit card members. Revenue concentration data is not disclosed, but the Life Assistance segment's dependency on a single credit card company raises potential concentration risk. Outlook data indicates a revenue growth trajectory of 3.2% for the current fiscal year and 4.1% for the next, driven by expanding insurance partnerships and geographic diversification. Capital expenditure is negative at JPY 37.2 million, suggesting asset optimization rather than expansion. Risk assessment highlights low dilution and liquidity risk, with no immediate filing-based flags detected. The debt-to-equity ratio of 0.57 suggests a conservative capital structure, but the company's reliance on cash reserves for liquidity may limit flexibility in capital deployment. Recent filings and transcripts show no material changes in operations or strategy. The company continues to focus on enhancing service offerings and expanding its insurance-linked product suite.

30-day price · 6063(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyEmergency Assistance Japan Co Ltd
Ticker6063.T
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Emergency Assistance Japan Co., Ltd. provides medical and life assistance services for overseas travelers, expatriates, and credit card members, generating revenue through insurance-linked services and concierge support.

Classification. Emergency Assistance Japan is classified in the Healthcare Facilities & Services industry under the Healthcare Services & Equipment business sector, with a confidence level of 0.92 based on verified market data.

Emergency Assistance Japan maintains a strong liquidity position with JPY 2.49 billion in cash and equivalents, representing 65.3% of total assets. The company's liquidity_fpt of 2.49 indicates a robust ability to cover short-term obligations, supported by a current ratio of 1.9. However, the low liquidity risk score suggests minimal pressure from short-term debt maturities. Profitability metrics show a return on equity (ROE) of 5.4% and return on assets (ROA) of 2.67%, both below the industry median for Healthcare Facilities & Services. The operating margin of 3.05% (JPY 113.4 million operating income on JPY 3.71 billion revenue) reflects moderate efficiency in converting revenue to profit. The company operates in two segments: Medical Assistance and Life Assistance. The Medical Assistance segment focuses on overseas medical support, while the Life Assistance segment provides concierge services for credit card members. Revenue concentration data is not disclosed, but the Life Assistance segment's dependency on a single credit card company raises potential concentration risk. Outlook data indicates a revenue growth trajectory of 3.2% for the current fiscal year and 4.1% for the next, driven by expanding insurance partnerships and geographic diversification. Capital expenditure is negative at JPY 37.2 million, suggesting asset optimization rather than expansion. Risk assessment highlights low dilution and liquidity risk, with no immediate filing-based flags detected. The debt-to-equity ratio of 0.57 suggests a conservative capital structure, but the company's reliance on cash reserves for liquidity may limit flexibility in capital deployment. Recent filings and transcripts show no material changes in operations or strategy. The company continues to focus on enhancing service offerings and expanding its insurance-linked product suite.
Key takeaways
  • Emergency Assistance Japan maintains a strong liquidity position with JPY 2.49 billion in cash and equivalents.
  • ROE of 5.4% and ROA of 2.67% indicate below-median profitability for the Healthcare Facilities & Services industry.
  • The Life Assistance segment's dependency on a single credit card company introduces potential concentration risk.
  • Revenue growth is projected at 3.2% for the current fiscal year and 4.1% for the next, driven by insurance partnerships.
  • The company's conservative debt-to-equity ratio of 0.57 supports financial stability but may limit capital flexibility.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$3.71B
Gross profit$872.0M
Operating income$113.4M
Net income$101.9M
R&D
SG&A
D&A
SBC
Operating cash flow$295.7M
CapEx-$37.2M
Free cash flow$90.0M
Total assets$3.81B
Total liabilities$1.93B
Total equity$1.89B
Cash & equivalents$2.49B
Long-term debt$1.08B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.89B
Net cash$1.41B
Current ratio1.9
Debt/Equity0.6
ROA2.7%
ROE5.4%
Cash conversion2.9%
CapEx/Revenue-1.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Pharmaceuticals · cohort 25 companies
Metric6063Activity
Op margin3.1%18.2% medp25 18.2% · p75 24.6%bottom quartile
Net margin2.7%14.7% medp25 11.7% · p75 28.1%bottom quartile
Gross margin23.5%19.7% medp25 19.7% · p75 39.8%above median
R&D / revenue24.3% medp25 6.6% · p75 24.3%
CapEx / revenue-1.0%4.9% medp25 4.2% · p75 6.3%bottom quartile
Debt / equity57.0%71.3% medp25 19.0% · p75 91.7%below median
Observations
IR observations
Last actual EPS40.44 JPY
Last actual revenue3,714,670,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 20:44 UTC#28431c73
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 20:46 UTCJob: c92cc001